mitomycin has been researched along with Cataract in 100 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the clinical outcome of eyes which underwent primary trabeculectomy with adjunctive mitomycin C (MMC) for primary glaucoma." | 8.79 | Mitomycin C primary trabeculectomy in primary glaucoma of white patients. ( Nuijts, RM; Vernimmen, RC; Webers, CA, 1997) |
| "We report on a 56-year-old male with primary open-angle glaucoma who underwent mitomycin C augmented canaloplasty enabling filtration in the right eye after cataract surgery combined with a Schlemm's canal microstent 3 years previously." | 8.12 | Canaloplasty with mitomycin C after previous combined cataract surgery and Schlemm's canal microstent implantation. ( Elksne, E; Mercieca, K; Prokosch-Willing, V, 2022) |
| "To analyze the effect of uneventful cataract surgery on intraocular pressure (IOP) in pseudoexfoliation glaucoma (PXG) eyes with and without a history of Mitomycin C-augmented trabeculectomy." | 8.12 | The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy. ( Alpogan, O; Ercalık, NY; Imamoglu, S; Kose, AO; Mangan, MS; Tekcan, H, 2022) |
| "Glaucoma surgery with the PSM and mitomycin C was efficacious and safe in the short term, either alone or in combination with cataract surgery, and may be considered a surgical option for lowering IOP in primary open angle glaucoma." | 8.12 | Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma. ( Caballero-Magro, E; Ibarz Barberá, M; Martínez-Galdón, F; Rodríguez-Piñero, M; Tañá-Rivero, P, 2022) |
| " It was the aim of this study to investigate the therapeutic success of Xen45 gel stents as a stand-alone technique (Xen) and combined with cataract surgery (XenPhaco), and with antimetabolites (mitomycin C, MMC) in open-angle glaucoma patients." | 8.02 | Influence of Mitomycin C on the Therapeutic Success of Stand-Alone Xen45 Gel Stents and Its Combination with Cataract Surgery in Open-Angle Glaucoma Patients. ( Denkel, L; Hohberger, B; Lämmer, R, 2021) |
| "To compare posterior capsule opacification (PCO) in rabbits who undergo cataract surgery and receive either mitomycin-C (MMC) or distilled water (DW) during sealed-capsule irrigation (SCI)." | 7.74 | Comparison of posterior capsule opacification in rabbits receiving either mitomycin-C or distilled water for sealed-capsule irrigation during cataract surgery. ( Choi, JS; Joo, CK; Kim, JH; Kim, SY, 2007) |
| "With adequate inflammation suppression, phacotrabeculectomy with mitomycin C is an effective and safe therapeutic option for the management of secondary cataract and glaucoma in uveitic eyes." | 7.73 | Phacotrabeculectomy with mitomycin C in patients with uveitis. ( Ahn, JK; Park, KH; Park, UC; Yu, HG, 2006) |
| "To characterise changes in ocular dimensions after combined cataract operation and trabeculectomy with mitomycin C using separate incisions (combined operation)." | 7.73 | Effects of combined cataract surgery and trabeculectomy with mitomycin C on ocular dimensions. ( Caprioli, J; Law, SK; Mansury, AM; Vasudev, D, 2005) |
| "To evaluate the safety and efficacy of trabeculectomy with or without mitomycin-C (MMC) in the management of glaucoma in aphakia and pseudophakia following congenital cataract surgery." | 7.72 | Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery. ( Bagga, H; Gothwal, VK; Mandal, AK; Nanda, AK; Nutheti, R, 2003) |
| "To present the clinical and histologic findings of a patient in whom intumescent cataract developed after successful topical mitomycin-C (MMC) chemotherapy for conjunctival melanoma originating from primary acquired conjunctival melanosis (PAM) with atypia." | 7.72 | Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma. ( Horvat, R; Lukas, JR; Sacu, S; Ségur-Eltz, N; Zehetmayer, M, 2003) |
| "Patients with both cataract and glaucoma underwent combined mitomycin C trabeculectomy, extracapsular cataract extraction, and intraocular lens implantation." | 7.69 | One-year follow-up results of combined mitomycin C trabeculectomy and extracapsular cataract extraction. ( Bueche, MJ; Feuer, WJ; Grajewski, AL; Joos, KM; Palmberg, PF, 1995) |
| "The use of topical mitomycin (mitomycin-C) as a medical adjunct to pterygium and glaucoma surgery is increasing." | 7.68 | Serious complications of topical mitomycin-C after pterygium surgery. ( Foster, CS; Martin, NF; Pfister, RR; Rubinfeld, RS; Speaker, MG; Stein, RM; Stoleru, S; Talley, AR, 1992) |
| "The mean intraocular pressures were significantly (P < ." | 6.69 | Limbus-based vs fornix-based conjunctival flap in combined glaucoma and cataract surgery with adjunctive mitomycin C. ( Bendel, RE; Hughes, BA; Juzych, MS; Kim, C; Lemon, LC; Shin, DH, 1998) |
| "Mitomycin C could cause the degeneration of lens epithelial cells." | 5.31 | [The inhibitory effect of mitomycin C applied by intracapsular method on rabbit lens epithelial cells: an experimental study of after-cataract]. ( Huang, J; Liu, Y; Zheng, D; Zheng, H, 2001) |
| "In this preliminary study, diclofenac sodium is at least as good as topical dexamethasone phosphate for glaucoma patients undergoing two-site combined phacotrabeculectomy with mitomycin C." | 5.17 | Postoperative treatment with topical diclofenac versus topical dexamethasone after combined phacotrabeculectomy with mitomycin C. ( Goldenfeld, M; Kalev-Landoi, M; Katz, G; Levkovitch-Verbin, H, 2013) |
| "To compare phacoemulsification versus trabeculectomy with adjunctive mitomycin C in medically uncontrolled chronic angle-closure glaucoma (CACG) without cataract." | 5.17 | Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. ( Baig, N; Kwong, YY; Lam, DS; Leung, DY; Li, FC; Tham, CC, 2013) |
| "Combined phacotrabeculectomy with adjunctive mitomycin C is more effective than phacoemulsification alone in controlling IOP in medically uncontrolled CACG eyes with coexisting cataract." | 5.14 | Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. ( Chan, JC; Chiu, TY; Kwong, YY; Lai, JS; Lam, DS; Lam, SW; Leung, DY; Li, FC; Tham, CC, 2009) |
| "Combined phacotrabeculectomy with adjunctive mitomycin C may be marginally more effective than phacoemulsification alone in controlling IOP in medically controlled CACG eyes with coexisting cataract." | 5.13 | Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract. ( Chan, CH; Chan, JC; Chi, CC; Chiu, TY; Kwong, YY; Lai, JS; Lam, DS; Lam, SW; Leung, DY; Li, FC; Poon, AS; Tham, CC; Yick, DW, 2008) |
| "To compare the intraocular pressure (IOP)-lowering effect of combined viscocanalostomy and phacoemulsification and combined trabeculectomy and phacoemulsification with mitomycin C in eyes with primary open-angle glaucoma." | 5.12 | Randomized comparison of the intraocular pressure-lowering effect of phacoviscocanalostomy and phacotrabeculectomy. ( Kobayashi, H; Kobayashi, K, 2007) |
| "Adjunctive subconjunctival mitomycin C did not further improve the final intraocular pressure outcome of the primary trabeculectomy combined with phacoemulsification and intraocular lens implantation in patients with primary open-angle glaucoma." | 5.08 | Adjunctive subconjunctival mitomycin C in glaucoma triple procedure. ( Hughes, BA; Juzych, MS; Kim, C; Reed, SY; Shin, DH; Simone, PA; Song, MS, 1995) |
| "The preponderance of evidence from the literature suggests a small (2-4 mmHg) benefit from the use of mitomycin-C (MMC), but not 5-fluorouracil (5-FU), in combined cataract and glaucoma surgery (evidence grade B)." | 4.81 | Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: An evidence-based review. ( Bass, EB; Congdon, N; Friedman, DS; Jampel, HD; Kempen, JH; Levkovitch-Verbin, H; Lubomski, LH; Quigley, H; Robinson, KA, 2002) |
| "To evaluate the clinical outcome of eyes which underwent primary trabeculectomy with adjunctive mitomycin C (MMC) for primary glaucoma." | 4.79 | Mitomycin C primary trabeculectomy in primary glaucoma of white patients. ( Nuijts, RM; Vernimmen, RC; Webers, CA, 1997) |
| " To assess the influence of cataract surgery following TE, eyes which underwent cataract surgery at least 6 months after TE were matched 1:3 by sex and age to eyes who did not undergo cataract surgery during the follow-up period." | 4.31 | Long-term success after trabeculectomy in open-angle glaucoma: results of a retrospective cohort study. ( Hoffmann, EM; Kianusch, K; Pfeiffer, N; Schuster, AK; Stingl, J; Wagner, FM, 2023) |
| "To analyze the effect of uneventful cataract surgery on intraocular pressure (IOP) in pseudoexfoliation glaucoma (PXG) eyes with and without a history of Mitomycin C-augmented trabeculectomy." | 4.12 | The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy. ( Alpogan, O; Ercalık, NY; Imamoglu, S; Kose, AO; Mangan, MS; Tekcan, H, 2022) |
| "Glaucoma surgery with the PSM and mitomycin C was efficacious and safe in the short term, either alone or in combination with cataract surgery, and may be considered a surgical option for lowering IOP in primary open angle glaucoma." | 4.12 | Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma. ( Caballero-Magro, E; Ibarz Barberá, M; Martínez-Galdón, F; Rodríguez-Piñero, M; Tañá-Rivero, P, 2022) |
| "We report on a 56-year-old male with primary open-angle glaucoma who underwent mitomycin C augmented canaloplasty enabling filtration in the right eye after cataract surgery combined with a Schlemm's canal microstent 3 years previously." | 4.12 | Canaloplasty with mitomycin C after previous combined cataract surgery and Schlemm's canal microstent implantation. ( Elksne, E; Mercieca, K; Prokosch-Willing, V, 2022) |
| " Trabeculectomy with or without augmentation with Mitomycin C(MMC) was the first-choice glaucoma incisional surgery for 96." | 4.12 | Surgical trends in glaucoma management: The current Indian scenario. ( Bhartiya, S; Ichhpujani, P; Kalra, G; Kumar, S; Singla, E, 2022) |
| "Sixty eyes of 60 patients complaining of primary open angle glaucoma and cataract, undergoing phaco-trabeculectomy, were distributed into three groups: group I: surgery was augmented with mitomycin C, group II with porcine extracellular matrix, and group III with porcine extracellular matrix combined with low dose mitomycin C." | 4.02 | The role of mitomycin C and porcine extracellular matrix in phacotrabeculectomy. ( Hamdi, IM; Hamdi, MM, 2021) |
| " It was the aim of this study to investigate the therapeutic success of Xen45 gel stents as a stand-alone technique (Xen) and combined with cataract surgery (XenPhaco), and with antimetabolites (mitomycin C, MMC) in open-angle glaucoma patients." | 4.02 | Influence of Mitomycin C on the Therapeutic Success of Stand-Alone Xen45 Gel Stents and Its Combination with Cataract Surgery in Open-Angle Glaucoma Patients. ( Denkel, L; Hohberger, B; Lämmer, R, 2021) |
| "To estimate the incidence and predisposing factors for cataract extraction (CE) after Deep Sclerectomy (DS) with Mitomycin-C (MMC) and its effect on intraocular pressure (IOP) control." | 3.91 | Cataract extraction after deep sclerectomy and its effect on intraocular pressure control. ( Anand, N; Darcy, K; Mercieca, K; Perumal, D, 2019) |
| "To evaluate the influence of phacoemulsification on intraocular pressure (IOP) control and survival of mitomycin C (MMC)-enhanced trabeculectomy in uveitic glaucoma (UG)." | 3.85 | The Influence of Phacoemulsification on Intraocular Pressure Control and Trabeculectomy Survival in Uveitic Glaucoma. ( Alharbi, AH; Aljadaan, I; Almobarak, FA; Morales, J, 2017) |
| "To determine the occurrence of intraoperative and postoperative complications up to three years after primary phacotrabeculectomy with intraoperative use of Mitomycin C (MMC) in primary open angle (POAG) and primary angle closure glaucoma (PACG) patients, and the effect of postoperative complications on surgical outcome." | 3.81 | Complications and outcomes of primary phacotrabeculectomy with mitomycin C in a multi-ethnic asian population. ( Aquino, MC; Chen, DZ; Chew, P; Koh, V; Sng, C, 2015) |
| " Data included patient demographics, pre- and postoperative intraocular pressure (IOP), use of mitomycin C (MMC), spacer device implantation, and follow-up details including surgical success rates." | 3.81 | Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study. ( Anand, N; Mercieca, K; Shevade, B, 2015) |
| "To compare the incidence of upper eyelid blepharoptosis after combined phacotrabeculectomy with mitomycin C and phacoemulsification surgeries and the relationship of bleb morphology to the incidence of ptosis." | 3.81 | Comparison of incidence of ptosis after combined phacotrabeculectomy with mitomycin C and phacoemulsification. ( Amrith, S; Chew, PT; Koh, V; Tatsios, J, 2015) |
| "To compare posterior capsule opacification (PCO) in rabbits who undergo cataract surgery and receive either mitomycin-C (MMC) or distilled water (DW) during sealed-capsule irrigation (SCI)." | 3.74 | Comparison of posterior capsule opacification in rabbits receiving either mitomycin-C or distilled water for sealed-capsule irrigation during cataract surgery. ( Choi, JS; Joo, CK; Kim, JH; Kim, SY, 2007) |
| "To determine the efficacy and safety of trabeculectomy with mitomycin-C (trabMMC) compared with that of single-site phacotrabeculectomy with mitomycin-C (phacotrabMMC) in glaucoma patients at increased risk for filtering surgery failure." | 3.73 | Trabeculectomy and phacotrabeculectomy, with mitomycin-C, show similar two-year target IOP outcomes. ( Damji, KF; Hodge, WG; Murthy, SK; Pan, Y, 2006) |
| "With adequate inflammation suppression, phacotrabeculectomy with mitomycin C is an effective and safe therapeutic option for the management of secondary cataract and glaucoma in uveitic eyes." | 3.73 | Phacotrabeculectomy with mitomycin C in patients with uveitis. ( Ahn, JK; Park, KH; Park, UC; Yu, HG, 2006) |
| "To characterise changes in ocular dimensions after combined cataract operation and trabeculectomy with mitomycin C using separate incisions (combined operation)." | 3.73 | Effects of combined cataract surgery and trabeculectomy with mitomycin C on ocular dimensions. ( Caprioli, J; Law, SK; Mansury, AM; Vasudev, D, 2005) |
| "To present the clinical and histologic findings of a patient in whom intumescent cataract developed after successful topical mitomycin-C (MMC) chemotherapy for conjunctival melanoma originating from primary acquired conjunctival melanosis (PAM) with atypia." | 3.72 | Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma. ( Horvat, R; Lukas, JR; Sacu, S; Ségur-Eltz, N; Zehetmayer, M, 2003) |
| "To evaluate the safety and efficacy of trabeculectomy with or without mitomycin-C (MMC) in the management of glaucoma in aphakia and pseudophakia following congenital cataract surgery." | 3.72 | Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery. ( Bagga, H; Gothwal, VK; Mandal, AK; Nanda, AK; Nutheti, R, 2003) |
| "Phacotrabeculectomy with intraoperative mitomycin C was successful in regard to both reduction of intraocular pressure and glaucoma medications." | 3.72 | Fornix vs limbus based flap in phacotrabeculetomy with mitomycin C: prospective study. ( Bencić, G; Bojić, L; Mandić, Z; Zorić Geber, M, 2004) |
| "02% mitomycin C (MMC) in glaucoma patients at risk for failure of filtration surgery." | 3.71 | Long term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure. ( Casson, R; Rahman, R; Salmon, JF, 2001) |
| "A concurrent series (from January 1, 1987, to October 1, 1997) of one surgeon's consecutive 585 (456 patients) combined cataract extraction, intraocular lens implantation, and trabeculectomy surgeries, some with intraoperative mitomycin C and/or postoperative subconjunctival 5-fluorouracil." | 3.70 | Outcomes of combined cataract extraction, lens implantation, and trabeculectomy surgeries. ( Hahn, J; Larive, B; Rockwood, EJ, 2000) |
| "Retrospective analysis of all eyes that underwent phacoemulsification surgery for symptomatic cataracts and had a preoperative diagnosis of chronic hypotony (intraocular pressure [IOP] mitomycin C." | 3.70 | Effect of phacoemulsification surgery on hypotony following trabeculectomy surgery. ( Doyle, JW; Smith, MF, 2000) |
| "Twenty-nine consecutive eyes of 26 patients with cataract and glaucoma that had undergone combined phacoemulsification, posterior chamber lens implantation, and limbus-based trabeculectomy with mitomycin-C applied after the cataract removal and trabeculectomy had a minimal follow-up time of 12 months (mean follow-up 20 +/- 6." | 3.69 | Midterm follow-up results of combined phacoemulsification, lens implantation, and mitomycin-C trabeculectomy procedure. ( Belyea, DA; Dan, JA; Lieberman, MF; Stamper, RL, 1997) |
| "We performed ultrasonography on a patient who, after trabeculectomy with mitomycin C, had an intraocular pressure of 1 mm Hg, an opaque cataract, and suspected hypotonous maculopathy in the left eye." | 3.69 | Echographic diagnosis of scleral fold in hypotony. ( DiBernardo, C; Loewenstein, A; McKinnon, S, 1997) |
| "Phacoemulsification combined with trabeculectomy using mitomycin-C appears to be an effective approach to the management of cataract in patients with glaucoma." | 3.69 | Combined phacoemulsification and trabeculectomy with mitomycin-C. ( Schuman, JS; Zacharia, PT, 1997) |
| "Patients with both cataract and glaucoma underwent combined mitomycin C trabeculectomy, extracapsular cataract extraction, and intraocular lens implantation." | 3.69 | One-year follow-up results of combined mitomycin C trabeculectomy and extracapsular cataract extraction. ( Bueche, MJ; Feuer, WJ; Grajewski, AL; Joos, KM; Palmberg, PF, 1995) |
| " Combined phacoemulsification and mitomycin C trabeculectomy appears to be safe and effective for treating selected patients with coexisting glaucoma and cataract." | 3.69 | Limbus- versus fornix-based conjunctival flaps in combined phacoemulsification and mitomycin C trabeculectomy surgery. ( Berestka, JS; Brown, SV, 1997) |
| "To prevent the development of secondary cataract, mitomycin C (MC, 0." | 3.69 | Prevention of secondary cataract by antimitotic drugs: experimental study. ( Alió, JL; Ismail, MM; Ruiz Moreno, JM, 1996) |
| "To determine whether there is increased risk to the corneal endothelium when mitomycin C is used in trabeculectomy surgery instead of fluorouracil, and whether these agents play a role in accelerating cataract formation." | 3.69 | Effect of mitomycin C and fluorouracil-supplemented trabeculectomies on the anterior segment. ( Chaturvedi, N; Dreyer, EB; Zurakowski, D, 1995) |
| "The glaucoma triple procedure with adjunctive mitomycin C appears to be a safe and effective surgical technique for treating selected patients with coexisting cataract and glaucoma." | 3.69 | Combined phacoemulsification, posterior chamber intraocular lens implantation, and trabeculectomy with mitomycin C. ( Alward, WL; Munden, PM, 1995) |
| "This study demonstrated that mitomycin has a significant inhibitory effect on secondary cataract formation (proliferation as well as fibrosis) in rabbits whereas heparin does not seem to have the same effectiveness." | 3.69 | Mitomycin against posterior capsular opacification: an experimental study in rabbits. ( Galand, AL; Haus, CM, 1996) |
| "The use of topical mitomycin (mitomycin-C) as a medical adjunct to pterygium and glaucoma surgery is increasing." | 3.68 | Serious complications of topical mitomycin-C after pterygium surgery. ( Foster, CS; Martin, NF; Pfister, RR; Rubinfeld, RS; Speaker, MG; Stein, RM; Stoleru, S; Talley, AR, 1992) |
| "In this pilot study with a small number of subjects, short-term outcomes suggest that subconjunctival bevacizumab is equally effective in reducing intraocular pressure with a better safety profile compared with MMC in the dosing schedule studied." | 2.77 | Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial. ( Ravindran, RD; Sengupta, S; Venkatesh, R, 2012) |
| "The mean intraocular pressures were significantly (P < ." | 2.69 | Limbus-based vs fornix-based conjunctival flap in combined glaucoma and cataract surgery with adjunctive mitomycin C. ( Bendel, RE; Hughes, BA; Juzych, MS; Kim, C; Lemon, LC; Shin, DH, 1998) |
| "Cataract and glaucoma are two very common conditions that frequently are coincident within the same patient." | 2.39 | Management of coincident glaucoma and cataract. ( Samuelson, TW, 1996) |
| "To determine the long-term outcomes of 2-site phacoemulsification combined with fornix-based trabeculectomy using mitomycin C (MMC) for primary angle-closure glaucoma (PACG) and primary open-angle glaucoma (POAG) in an Asian population." | 1.46 | Success rates of 2-site phacoemulsification combined with fornix-based trabeculectomy using mitomycin C for primary angle-closure glaucoma and primary open-angle glaucoma in an Asian population. ( Aduan, J; Aquino, CM; Chee, LS; Chen, D; Chew, P; Koh, V; Sng, C, 2017) |
| "To determine the efficacy of safe surgery system trabeculectomy combined with manual small incision cataract surgery/phacoemulsification in primary glaucoma coexistent with cataract." | 1.42 | Surgical outcome of safe surgery system trabeculectomy combined with cataract extraction. ( Agashe, A; Khandelwal, R; Khandelwal, RR; Majumdar, M; Raje, D; Rathi, A, 2015) |
| " There was similar frequency (<10%) of adverse events in both groups, and there were no complications directly related to the Ologen implant." | 1.39 | Efficacy and safety of collagen matrix implants in phacotrabeculectomy and comparison with mitomycin C augmented phacotrabeculectomy at 1 year. ( Aung, T; Hoh, ST; Htoon, HM; Narayanaswamy, A; Perera, SA; Seah, SK; Wong, TT, 2013) |
| "We report a case of suprachoroidal hemorrhage following removal of a releasable suture after combined phacoemulsification-trabeculectomy." | 1.34 | Suprachoroidal hemorrhage following removal of releasable suture after combined phacoemulsification-trabeculectomy. ( Eong, KG; Prashanth, S; Raman, GV; Sathyan, P; Singh, G, 2007) |
| "Diclofenac was less effective but also reduced PCO." | 1.31 | Prevention of posterior capsule opacification by intraoperative single-dose pharmacologic agents. ( Emiroğlu, L; Güler, C; Ilker, SS; Kaynak, S; Kurt, E; Ozer, E; Oztürk, F, 2001) |
| " The optimal biocompatible dosage must be carefully determined by further investigation." | 1.31 | Prevention of posterior capsule opacification by retinoic acid and mitomycin. ( Güler, C; Ilker, SS; Inan, UU; Kaynak, S; Ozer, E; Oztürk, F, 2001) |
| "Mitomycin C could cause the degeneration of lens epithelial cells." | 1.31 | [The inhibitory effect of mitomycin C applied by intracapsular method on rabbit lens epithelial cells: an experimental study of after-cataract]. ( Huang, J; Liu, Y; Zheng, D; Zheng, H, 2001) |
| "Intraocular pressures were lower in the group that received MMC compared to the 5-FU group, but not in the group that did not receive antimetabolites, at all time intervals measured (P < ." | 1.30 | Comparison of phacotrabeculectomy with 5-fluorouracil, mitomycin-C, and without antifibrotic agents. ( Budenz, DL; Gordon, J; Keates, EU; Piltz-Seymour, J; Pyfer, M; Singh, K, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 25 (25.00) | 18.2507 |
| 2000's | 41 (41.00) | 29.6817 |
| 2010's | 23 (23.00) | 24.3611 |
| 2020's | 11 (11.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ichhpujani, P | 1 |
| Singla, E | 1 |
| Kalra, G | 1 |
| Bhartiya, S | 1 |
| Kumar, S | 1 |
| Monja-Alarcón, N | 1 |
| Perucho-Martínez, S | 1 |
| Buenasmañanas-Maeso, M | 1 |
| Toledano-Fernández, N | 1 |
| Almobarak, FA | 2 |
| Alharbi, AH | 2 |
| Aljadaan, I | 2 |
| Aldhibi, H | 1 |
| Tekcan, H | 1 |
| Mangan, MS | 1 |
| Alpogan, O | 1 |
| Imamoglu, S | 1 |
| Kose, AO | 1 |
| Ercalık, NY | 1 |
| Ibarz Barberá, M | 1 |
| Martínez-Galdón, F | 1 |
| Caballero-Magro, E | 1 |
| Rodríguez-Piñero, M | 1 |
| Tañá-Rivero, P | 1 |
| Gedde, SJ | 2 |
| Feuer, WJ | 3 |
| Lim, KS | 1 |
| Barton, K | 1 |
| Goyal, S | 2 |
| Ahmed, II | 1 |
| Brandt, JD | 1 |
| Wagner, FM | 1 |
| Schuster, AK | 1 |
| Kianusch, K | 1 |
| Stingl, J | 1 |
| Pfeiffer, N | 1 |
| Hoffmann, EM | 1 |
| Pathak Ray, V | 1 |
| Chaironika, N | 1 |
| Gupta, S | 1 |
| Choudhari, NS | 2 |
| Hamdi, MM | 1 |
| Hamdi, IM | 1 |
| Elksne, E | 1 |
| Mercieca, K | 3 |
| Prokosch-Willing, V | 1 |
| Mokkarala, AJR | 1 |
| Tone, B | 1 |
| Khanna, R | 1 |
| Garudadri, CS | 2 |
| Denkel, L | 1 |
| Hohberger, B | 1 |
| Lämmer, R | 1 |
| Vinod, K | 1 |
| Panarelli, JF | 1 |
| Chang, TC | 1 |
| Chen, PP | 1 |
| Parrish, RK | 1 |
| Perumal, D | 1 |
| Darcy, K | 1 |
| Anand, N | 4 |
| Paletta Guedes, RA | 1 |
| Gravina, DM | 1 |
| Paletta Guedes, VM | 1 |
| Chaoubah, A | 1 |
| Wlaź, A | 1 |
| Wilkos-Kuc, A | 1 |
| Rozegnał-Madej, A | 1 |
| Żarnowski, T | 1 |
| E Graf, N | 1 |
| Müller, M | 1 |
| Gerlach, F | 1 |
| M Meyer, L | 1 |
| Philipp, S | 1 |
| Distelmaier, P | 1 |
| Klink, T | 1 |
| Schönfeld, CL | 1 |
| Yuksel, D | 1 |
| Kosker, M | 1 |
| Reddy, JC | 1 |
| Celik, T | 1 |
| Ogata-Iwao, M | 1 |
| Inatani, M | 1 |
| Takihara, Y | 1 |
| Inoue, T | 1 |
| Iwao, K | 1 |
| Tanihara, H | 1 |
| Darian-Smith, E | 1 |
| Toh, T | 1 |
| Khandelwal, RR | 1 |
| Raje, D | 1 |
| Rathi, A | 1 |
| Agashe, A | 1 |
| Majumdar, M | 1 |
| Khandelwal, R | 1 |
| Chen, DZ | 1 |
| Koh, V | 3 |
| Sng, C | 2 |
| Aquino, MC | 1 |
| Chew, P | 2 |
| Na, JH | 1 |
| Sung, KR | 1 |
| Shin, JA | 1 |
| Moon, JI | 1 |
| Shevade, B | 1 |
| Tatsios, J | 1 |
| Chew, PT | 1 |
| Amrith, S | 1 |
| Pérez-Torregrosa, VT | 1 |
| Olate-Pérez, Á | 1 |
| Cerdà-Ibáñez, M | 1 |
| Gargallo-Benedicto, A | 1 |
| Osorio-Alayo, V | 1 |
| Barreiro-Rego, A | 1 |
| Duch-Samper, A | 1 |
| Chen, D | 1 |
| Aquino, CM | 1 |
| Aduan, J | 1 |
| Chee, LS | 1 |
| Morales, J | 1 |
| Tham, CC | 3 |
| Kwong, YY | 3 |
| Leung, DY | 3 |
| Lam, SW | 2 |
| Li, FC | 3 |
| Chiu, TY | 2 |
| Chan, JC | 2 |
| Chan, CH | 1 |
| Poon, AS | 1 |
| Yick, DW | 1 |
| Chi, CC | 1 |
| Lam, DS | 3 |
| Lai, JS | 2 |
| Nazm, N | 1 |
| Gandhi, M | 1 |
| Dubey, S | 1 |
| Pegu, J | 1 |
| Iyer, JV | 1 |
| Perera, SA | 2 |
| Aung, T | 2 |
| Rao, HL | 1 |
| Maheshwari, R | 1 |
| Senthil, S | 1 |
| Prasad, KK | 1 |
| Emarah, AM | 1 |
| El-Helw, MA | 1 |
| Sengupta, S | 1 |
| Venkatesh, R | 1 |
| Ravindran, RD | 1 |
| Levkovitch-Verbin, H | 2 |
| Katz, G | 1 |
| Kalev-Landoi, M | 1 |
| Goldenfeld, M | 1 |
| Baig, N | 1 |
| Narayanaswamy, A | 1 |
| Htoon, HM | 1 |
| Hoh, ST | 1 |
| Seah, SK | 1 |
| Wong, TT | 1 |
| Shin, DH | 7 |
| Iskander, NG | 1 |
| Ahee, JA | 1 |
| Singal, IP | 1 |
| Kim, C | 6 |
| Hughes, BA | 5 |
| Eliassi-Rad, B | 1 |
| Kim, YY | 2 |
| Kozobolis, VP | 1 |
| Siganos, CS | 1 |
| Christodoulakis, EV | 1 |
| Lazarov, NP | 1 |
| Koutentaki, MG | 1 |
| Pallikaris, IG | 1 |
| Jampel, HD | 1 |
| Friedman, DS | 1 |
| Lubomski, LH | 1 |
| Kempen, JH | 1 |
| Quigley, H | 1 |
| Congdon, N | 1 |
| Robinson, KA | 1 |
| Bass, EB | 1 |
| Zheng, D | 1 |
| Liu, Y | 1 |
| Huang, J | 1 |
| Zheng, H | 1 |
| Mandal, AK | 1 |
| Bagga, H | 1 |
| Nutheti, R | 1 |
| Gothwal, VK | 1 |
| Nanda, AK | 1 |
| Sacu, S | 1 |
| Ségur-Eltz, N | 1 |
| Horvat, R | 1 |
| Lukas, JR | 1 |
| Zehetmayer, M | 1 |
| Miyamoto, T | 1 |
| Saika, S | 1 |
| Okada, Y | 1 |
| Ishida-Nishikawa, I | 1 |
| Sumioka, T | 1 |
| Fujita, N | 1 |
| Ohnishi, Y | 1 |
| Mandić, Z | 1 |
| Bencić, G | 1 |
| Zorić Geber, M | 1 |
| Bojić, L | 1 |
| O'Brart, DP | 1 |
| Shiew, M | 1 |
| Edmunds, B | 1 |
| Pfister, RR | 2 |
| Alzafiri, Y | 1 |
| Harasymowycz, P | 1 |
| Fernandez, V | 1 |
| Fragoso, MA | 1 |
| Billotte, C | 1 |
| Lamar, P | 1 |
| Orozco, MA | 1 |
| Dubovy, S | 1 |
| Willcox, M | 1 |
| Parel, JM | 1 |
| Funnell, CL | 1 |
| Clowes, M | 1 |
| Landa, G | 1 |
| Pollack, A | 1 |
| Rachmiel, R | 1 |
| Bukelman, A | 1 |
| Marcovich, A | 1 |
| Zalish, M | 1 |
| Law, SK | 1 |
| Mansury, AM | 1 |
| Vasudev, D | 1 |
| Caprioli, J | 1 |
| Murthy, SK | 1 |
| Damji, KF | 1 |
| Pan, Y | 1 |
| Hodge, WG | 1 |
| Banitt, M | 1 |
| Juzych, MS | 4 |
| Chopra, V | 1 |
| Shingleton, BJ | 2 |
| Price, RS | 1 |
| O'Donoghue, MW | 2 |
| Li, G | 1 |
| Kasner, O | 1 |
| Park, UC | 1 |
| Ahn, JK | 1 |
| Park, KH | 1 |
| Yu, HG | 1 |
| Chakraborty, D | 1 |
| Dutta Choudhury, B | 1 |
| Kobayashi, H | 1 |
| Kobayashi, K | 1 |
| Anand, S | 1 |
| Sathyan, P | 2 |
| Singh, G | 1 |
| Eong, KG | 1 |
| Raman, GV | 1 |
| Prashanth, S | 1 |
| Cotran, PR | 1 |
| Roh, S | 1 |
| McGwin, G | 1 |
| Kim, SY | 1 |
| Kim, JH | 1 |
| Choi, JS | 1 |
| Joo, CK | 1 |
| Dreyer, EB | 1 |
| Chaturvedi, N | 1 |
| Zurakowski, D | 1 |
| Munden, PM | 1 |
| Alward, WL | 1 |
| Joos, KM | 1 |
| Bueche, MJ | 1 |
| Palmberg, PF | 1 |
| Grajewski, AL | 1 |
| Ismail, MM | 1 |
| Alió, JL | 1 |
| Ruiz Moreno, JM | 1 |
| Berestka, JS | 1 |
| Brown, SV | 1 |
| Haus, CM | 1 |
| Galand, AL | 1 |
| Simone, PA | 1 |
| Song, MS | 2 |
| Reed, SY | 2 |
| Belyea, DA | 1 |
| Dan, JA | 1 |
| Lieberman, MF | 1 |
| Stamper, RL | 1 |
| Yang, KJ | 2 |
| Moster, MR | 1 |
| Azuara-Blanco, A | 1 |
| Wilson, RP | 1 |
| Araujo, SV | 1 |
| Schmidt, CM | 1 |
| Tezel, G | 1 |
| Kolker, AE | 1 |
| Kass, MA | 1 |
| Wax, MB | 1 |
| Loewenstein, A | 1 |
| McKinnon, S | 1 |
| DiBernardo, C | 1 |
| Zacharia, PT | 1 |
| Schuman, JS | 1 |
| Nuijts, RM | 1 |
| Vernimmen, RC | 1 |
| Webers, CA | 1 |
| Lemon, LC | 2 |
| Bendel, RE | 1 |
| Ren, J | 2 |
| Glover, KB | 2 |
| Weatherwax, AL | 1 |
| Pearlman, RB | 1 |
| Muenk, SB | 1 |
| Daugeliene, L | 1 |
| Yamamoto, T | 1 |
| Sawada, A | 1 |
| Kitazawa, Y | 1 |
| Weene, LE | 1 |
| Derick, RJ | 1 |
| Evans, J | 1 |
| Baker, ND | 1 |
| Samuelson, TW | 3 |
| Budenz, DL | 1 |
| Pyfer, M | 1 |
| Singh, K | 1 |
| Gordon, J | 1 |
| Piltz-Seymour, J | 1 |
| Keates, EU | 1 |
| Gayton, JL | 1 |
| Van Der Karr, M | 1 |
| Sanders, V | 1 |
| Doyle, JW | 1 |
| Smith, MF | 1 |
| Ober, MD | 1 |
| Nootheti, P | 1 |
| Cha, SC | 1 |
| Kim, PH | 2 |
| Chung, HS | 1 |
| Lim, SJ | 1 |
| Kim, HB | 1 |
| Rockwood, EJ | 1 |
| Larive, B | 1 |
| Hahn, J | 1 |
| Casson, R | 1 |
| Rahman, R | 1 |
| Salmon, JF | 2 |
| Oztürk, F | 2 |
| Kaynak, S | 2 |
| Kurt, E | 1 |
| Emiroğlu, L | 1 |
| Ozer, E | 2 |
| Ilker, SS | 2 |
| Güler, C | 2 |
| Inan, UU | 1 |
| Casson, RJ | 1 |
| Vandenbelt, SM | 1 |
| Gross, JP | 1 |
| Keole, NS | 1 |
| Lee, SH | 1 |
| Birt, CM | 1 |
| Chaudhry, IM | 1 |
| Rubinfeld, RS | 1 |
| Stein, RM | 1 |
| Foster, CS | 1 |
| Martin, NF | 1 |
| Stoleru, S | 1 |
| Talley, AR | 1 |
| Speaker, MG | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of Macular Thickness in Patients With Glaucoma in Use of Topical Prostaglandin Analogue Undergoing Trabeculectomy With Mitomycin C[NCT06000280] | 37 participants (Actual) | Interventional | 2021-01-04 | Completed | |||
| Glaucoma Including Pseudoexfoliation Syndrome (SFB 539)[NCT00494923] | 2,500 participants (Anticipated) | Observational | 1999-01-31 | Recruiting | |||
| Phaco-UCP; Combined Phacoemulsification and Ultrasound Ciliary Plasty Versus Phacoemulsification Alone for Management of Coexisting Cataract and Open Angle Glaucoma[NCT04430647] | 61 participants (Actual) | Interventional | 2018-03-01 | Completed | |||
| XEN45 Gel Stent Implantation in Glaucoma Surgery[NCT03138928] | 15 participants (Actual) | Observational | 2015-01-31 | Completed | |||
| Comparison of Combined Phacotrabeculectomy and Trabeculectomy Only in the Treatment of Primary Angle-closure Glaucoma[NCT01298635] | 31 participants (Actual) | Interventional | 2005-01-31 | Completed | |||
| Prospective Study on Ex-PRESS Implantation Combined With Phacoemulsification in Primary Angle-closure Glaucoma[NCT03323138] | 40 participants (Anticipated) | Interventional | 2012-07-01 | Recruiting | |||
| Effectiveness and Safety of Trabeculectomy and Peripheral Iridectomy Plus Goniotomy in Advanced Primary Angle-closure Glaucoma: a Multicenter Non-inferiority Randomized Controlled Trial[NCT05163951] | 88 participants (Anticipated) | Interventional | 2022-01-05 | Recruiting | |||
| Effectiveness and Safety of Phacotrabeculectomy and Phacogoniotomy in Advanced Primary Angle-closure Glaucoma: a Multicenter Randomized Controlled Trial[NCT04878458] | 124 participants (Actual) | Interventional | 2021-05-31 | Active, not recruiting | |||
| Combined Phacoemulsification and Viscocanalostomy With Ologen Implant Versus Combined Phacoemulsification and Viscocanalostomy[NCT03782051] | 81 participants (Actual) | Interventional | 2013-08-01 | Completed | |||
| Intraocular Pressure Control Following One Site Versus Two Site Combined Phacoemulsification/IOL And Trabeculectomy[NCT00695747] | 95 participants (Actual) | Interventional | 1998-01-31 | Completed | |||
| Modified Trabeculectomy With an Extended Subscleral Tunnel Versus Conventional Trabeculectomy for Management of Primary Open Angle Glaucoma (POAG)[NCT03480711] | 40 participants (Actual) | Interventional | 2018-07-10 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for mitomycin and Cataract
| Article | Year |
|---|---|
Effect of technique on intraocular pressure after combined cataract and glaucoma surgery: An evidence-based review.
Topics: Antimetabolites, Antineoplastic; Cataract; Cataract Extraction; Evidence-Based Medicine; Fluorouraci | 2002 |
Mitomycin C primary trabeculectomy in primary glaucoma of white patients.
Topics: Antimetabolites; Cataract; Disease Progression; Glaucoma; Humans; Intraocular Pressure; Intraoperati | 1997 |
Management of coincident glaucoma and cataract.
Topics: Cataract; Cataract Extraction; Exfoliation Syndrome; Fluorouracil; Glaucoma; Humans; Lenses, Intraoc | 1995 |
Management of coincident glaucoma and cataract.
Topics: Cataract; Cataract Extraction; Chemotherapy, Adjuvant; Glaucoma; Humans; Mitomycin; Trabeculectomy | 1996 |
Management of coincident glaucoma and cataract.
Topics: Cataract; Cataract Extraction; Filtering Surgery; Glaucoma; Humans; Intraocular Pressure; Mitomycin; | 1999 |
Combined surgery in the treatment of patients with cataract and primary open-angle glaucoma.
Topics: Cataract; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lens Implantation, Intraocular; Mitomy | 2001 |
21 trials available for mitomycin and Cataract
| Article | Year |
|---|---|
Postoperative Complications in the Primary Tube Versus Trabeculectomy Study During 5 Years of Follow-up.
Topics: Alkylating Agents; Blindness; Cataract; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Hum | 2022 |
Phacotrabeculectomy using collagen matrix implant (Ologen
Topics: Aged; Alkylating Agents; Cataract; Collagen; Drug Implants; Female; Follow-Up Studies; Glaucoma; Gly | 2019 |
Combined phacoemulsification and XEN45 surgery from a temporal approach and 2 incisions.
Topics: Cataract; Collagen; Combined Modality Therapy; Gels; Glaucoma Drainage Implants; Glaucoma, Open-Angl | 2016 |
Phacoemulsification versus combined phacotrabeculectomy in medically controlled chronic angle closure glaucoma with cataract.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Disease; Fema | 2008 |
Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Disease; Fema | 2009 |
Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Disease; Fema | 2009 |
Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Disease; Fema | 2009 |
Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Disease; Fema | 2009 |
Anterior lens capsule versus mitomycin-C as an adjunct to trabeculectomy in combined phacotrabeculectomy.
Topics: Aged; Alkylating Agents; Cataract; Female; Glaucoma; Humans; Intraocular Pressure; Lens Capsule, Cry | 2011 |
Safety and efficacy of using off-label bevacizumab versus mitomycin C to prevent bleb failure in a single-site phacotrabeculectomy by a randomized controlled clinical trial.
Topics: Aged; Alkylating Agents; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Ca | 2012 |
Postoperative treatment with topical diclofenac versus topical dexamethasone after combined phacotrabeculectomy with mitomycin C.
Topics: Administration, Topical; Aged; Alkylating Agents; Anti-Inflammatory Agents, Non-Steroidal; Cataract; | 2013 |
Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Diseas | 2013 |
Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Diseas | 2013 |
Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Diseas | 2013 |
Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract.
Topics: Adult; Aged; Aged, 80 and over; Alkylating Agents; Antihypertensive Agents; Cataract; Chronic Diseas | 2013 |
Two-site phacotrabeculectomy with intraoperative mitomycin-C: fornix- versus limbus-based conjunctival opening in fellow eyes.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Conjunctiva; Female; Glaucoma, Open-Angle; Humans; Intr | 2002 |
A randomised, prospective study comparing trabeculectomy with viscocanalostomy with adjunctive antimetabolite usage for the management of open angle glaucoma uncontrolled by medical therapy.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Blister; Cataract; Female; Filtering Surgery; Fluor | 2004 |
Comparison of 1-site versus 2-site phacotrabeculectomy.
Topics: Antihypertensive Agents; Case-Control Studies; Cataract; Fluorouracil; Follow-Up Studies; Glaucoma; | 2006 |
Randomized comparison of the intraocular pressure-lowering effect of phacoviscocanalostomy and phacotrabeculectomy.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Cataract; Catheterization; Chronic Disease; Female; Glau | 2007 |
Randomized comparison of 1-Site and 2-Site phacotrabeculectomy with 3-year follow-up.
Topics: Aged; Aged, 80 and over; Antihypertensive Agents; Cataract; Female; Follow-Up Studies; Glaucoma, Ope | 2008 |
Adjunctive subconjunctival mitomycin C in glaucoma triple procedure.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Chemotherapy, Adjuvant; Conjunctiva; Female; Follow-Up | 1995 |
Limbus-based vs fornix-based conjunctival flap in combined glaucoma and cataract surgery with adjunctive mitomycin C.
Topics: Aged; Cataract; Chemotherapy, Adjuvant; Conjunctiva; Female; Glaucoma, Open-Angle; Humans; Intraocul | 1998 |
Primary glaucoma triple procedure in patients with primary open-angle glaucoma: the effect of mitomycin C in patients with and without prognostic factors for filtration failure.
Topics: Aged; Cataract; Chemotherapy, Adjuvant; Female; Glaucoma, Open-Angle; Humans; Lens Implantation, Int | 1998 |
Decrease of capsular opacification with adjunctive mitomycin C in combined glaucoma and cataract surgery.
Topics: Aged; Aged, 80 and over; Cataract; Cataract Extraction; Chemotherapy, Adjuvant; Female; Glaucoma, Op | 1998 |
Combined phacoemulsification and trabeculectomy versus trabeculectomy alone: a comparison study using mitomycin-C.
Topics: Aged; Aged, 80 and over; Cataract; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure | 1998 |
Combined cataract and glaucoma surgery: trabeculectomy versus endoscopic laser cycloablation.
Topics: Cataract; Ciliary Body; Endoscopy; Female; Fluorouracil; Follow-Up Studies; Glaucoma; Humans; Intrao | 1999 |
Posterior capsular opacification in phacotrabeculectomy : a long-term comparative study of silicone versus acrylic intraocular lens.
Topics: Acrylic Resins; Adult; Aged; Aged, 80 and over; Cataract; Chemotherapy, Adjuvant; Female; Follow-Up | 2000 |
73 other studies available for mitomycin and Cataract
| Article | Year |
|---|---|
Surgical trends in glaucoma management: The current Indian scenario.
Topics: Cataract; Child; Glaucoma; Glaucoma Drainage Implants; Humans; Intraocular Pressure; Mitomycin; Trab | 2022 |
Does mitomycin-C concentration have any influence on XEN45 gel stent outcomes in a real-world setting?
Topics: Cataract; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Retrospective Studies; Sten | 2022 |
Phacoemulsification after trabeculectomy in uveitis associated with Vogt-Koyanagi-Harada disease: intermediate-term visual outcome, IOP control and trabeculectomy survival.
Topics: Cataract; Humans; Intraocular Pressure; Mitomycin; Phacoemulsification; Retrospective Studies; Trabe | 2022 |
The effect of uneventful cataract surgery in pseudoexfoliation glaucoma with or without previous mitomycin C-augmented trabeculectomy.
Topics: Cataract; Exfoliation Syndrome; Glaucoma; Humans; Intraocular Pressure; Lens Implantation, Intraocul | 2022 |
Efficacy and Safety of the Preserflo Microshunt With Mitomycin C for the Treatment of Open Angle Glaucoma.
Topics: Antihypertensive Agents; Cataract; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mit | 2022 |
Long-term success after trabeculectomy in open-angle glaucoma: results of a retrospective cohort study.
Topics: Cataract; Eye; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; Ret | 2023 |
New superior modified fornix-based twin-site phacotrabeculectomy.
Topics: Antibiotics, Antineoplastic; Cataract; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; Mitomy | 2019 |
The role of mitomycin C and porcine extracellular matrix in phacotrabeculectomy.
Topics: Adult; Aged; Alkylating Agents; Cataract; Collagen; Drug Combinations; Female; Glaucoma, Open-Angle; | 2021 |
Canaloplasty with mitomycin C after previous combined cataract surgery and Schlemm's canal microstent implantation.
Topics: Cataract; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Mitomycin; Trabecul | 2022 |
Modifications to Combined Trabeculectomy and Manual Small Incision Cataract Surgery: Outcomes and Adaptability in Resource-constrained Areas.
Topics: Adult; Aged; Cataract; Follow-Up Studies; Humans; Intraocular Pressure; Mitomycin; Ophthalmology; Re | 2021 |
Influence of Mitomycin C on the Therapeutic Success of Stand-Alone Xen45 Gel Stents and Its Combination with Cataract Surgery in Open-Angle Glaucoma Patients.
Topics: Cataract; Glaucoma Drainage Implants; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Mitomycin; | 2021 |
Practice Preferences for Glaucoma Surgery: A Survey of the American Glaucoma Society.
Topics: Alkylating Agents; Cataract; Female; Filtering Surgery; Fluorouracil; Glaucoma Drainage Implants; Gl | 2017 |
Cataract extraction after deep sclerectomy and its effect on intraocular pressure control.
Topics: Age Factors; Aged; Analysis of Variance; Cataract; Cataract Extraction; Female; Humans; Intraocular | 2019 |
Use of a Collagen Matrix Implant as an Adjuvant in Combined Surgery Involving Phacoemulsification and Nonpenetrating Deep Sclerectomy.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Cataract; Collagen; Exfoliation Syndrome; Female; Glauco | 2019 |
Comparison of 2-year-results of mitomycin C-augmented trabeculectomy with or without cataract extraction in glaucoma patients.
Topics: Adult; Aged; Aged, 80 and over; Cataract; Cataract Extraction; Female; Follow-Up Studies; Glaucoma; | 2019 |
Management of cataracts and oculo-cutaneous malignancy in xeroderma pigmentosum.
Topics: Adolescent; Biological Dressings; Carcinoma, Squamous Cell; Cataract; Conjunctival Neoplasms; Female | 2013 |
A prospective comparison between trabeculectomy with mitomycin C and phacotrabeculectomy with mitomycin C.
Topics: Aged; Alkylating Agents; Cataract; Exfoliation Syndrome; Female; Glaucoma, Open-Angle; Humans; Intra | 2013 |
Corneal decompensation following bleb needling with 0.01% mitomycin C: a case study.
Topics: Aged; Alkylating Agents; Cataract; Combined Modality Therapy; Conjunctiva; Corneal Edema; Female; Gl | 2014 |
Surgical outcome of safe surgery system trabeculectomy combined with cataract extraction.
Topics: Alkylating Agents; Cataract; Cataract Extraction; Female; Glaucoma, Angle-Closure; Glaucoma, Open-An | 2015 |
Complications and outcomes of primary phacotrabeculectomy with mitomycin C in a multi-ethnic asian population.
Topics: Aged; Asian People; Cataract; Cataract Extraction; Female; Glaucoma, Angle-Closure; Glaucoma, Open-A | 2015 |
Antifibrotic effects of pirfenidone on Tenon's fibroblasts in glaucomatous eyes: comparison with mitomycin C and 5-fluorouracil.
Topics: Actins; Adult; Alkylating Agents; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Catara | 2015 |
Outcomes of combined phacoemulsification and deep sclerectomy: a 10-year UK single-centre study.
Topics: Aged; Aged, 80 and over; Alkylating Agents; Cataract; Female; Glaucoma; Humans; Intraocular Pressure | 2015 |
Comparison of incidence of ptosis after combined phacotrabeculectomy with mitomycin C and phacoemulsification.
Topics: Aged; Alkylating Agents; Blepharoptosis; Cataract; Combined Modality Therapy; Female; Glaucoma; Huma | 2015 |
Success rates of 2-site phacoemulsification combined with fornix-based trabeculectomy using mitomycin C for primary angle-closure glaucoma and primary open-angle glaucoma in an Asian population.
Topics: Aged; Cataract; Female; Follow-Up Studies; Glaucoma, Angle-Closure; Glaucoma, Open-Angle; Humans; In | 2017 |
The Influence of Phacoemulsification on Intraocular Pressure Control and Trabeculectomy Survival in Uveitic Glaucoma.
Topics: Adult; Alkylating Agents; Antihypertensive Agents; Case-Control Studies; Cataract; Female; Glaucoma, | 2017 |
Angle closure glaucoma.
Topics: Antihypertensive Agents; Cataract; Chronic Disease; Glaucoma, Angle-Closure; Humans; Intraocular Pre | 2009 |
Phacoemulsification and glaucoma.
Topics: Antihypertensive Agents; Cataract; Chronic Disease; Glaucoma, Angle-Closure; Humans; Intraocular Pre | 2009 |
Phacotrabeculectomy without mitomycin C in primary angle-closure and open-angle glaucoma.
Topics: Alkylating Agents; Antihypertensive Agents; Cataract; Female; Follow-Up Studies; Glaucoma, Angle-Clo | 2011 |
Efficacy and safety of collagen matrix implants in phacotrabeculectomy and comparison with mitomycin C augmented phacotrabeculectomy at 1 year.
Topics: Absorbable Implants; Aged; Alkylating Agents; Cataract; Collagen; Female; Glaucoma; Glycosaminoglyca | 2013 |
Long-term filtration and visual field outcomes after primary glaucoma triple procedure with and without mitomycin-C.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans | 2002 |
[The inhibitory effect of mitomycin C applied by intracapsular method on rabbit lens epithelial cells: an experimental study of after-cataract].
Topics: Animals; Antimetabolites, Antineoplastic; Cataract; Epithelial Cells; Female; Follow-Up Studies; Int | 2001 |
Trabeculectomy with or without mitomycin-C for paediatric glaucoma in aphakia and pseudophakia following congenital cataract surgery.
Topics: Adolescent; Aphakia, Postcataract; Cataract; Cataract Extraction; Chemotherapy, Adjuvant; Child; Chi | 2003 |
Intumescent cataract after topical mitomycin-C for conjunctival malignant melanoma.
Topics: Administration, Topical; Antibiotics, Antineoplastic; Cataract; Cataract Extraction; Conjunctival Ne | 2003 |
Topical exposure of mitomycin C reduces opacification of the residual anterior lens capsule and lenticular regeneration after vitrectomy and lensectomy in rabbits.
Topics: Administration, Topical; Animals; Antibiotics, Antineoplastic; Cataract; Epithelial Cells; Lens Caps | 2004 |
Fornix vs limbus based flap in phacotrabeculetomy with mitomycin C: prospective study.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Conjunctiva; Female; Glaucoma, Open-Angle; Humans; Intr | 2004 |
Permanent corneal edema resulting from the treatment of PTK corneal haze with mitomycin: a case report.
Topics: Adult; Cataract; Corneal Edema; Corneal Surgery, Laser; Humans; Keratoplasty, Penetrating; Male; Mit | 2004 |
Foldable acrylic versus rigid polymethylmethacrylate intraocular lens in combined phacoemulsification and trabeculectomy.
Topics: Aged; Antibiotics, Antineoplastic; Biocompatible Materials; Cataract; Glaucoma; Hospitals, Universit | 2004 |
Efficacy of various drugs in the prevention of posterior capsule opacification: experimental study of rabbit eyes.
Topics: Acetates; Acetic Acid; Animals; Capsulorhexis; Cataract; Cell Proliferation; Drug Combinations; Edet | 2004 |
Combined cataract and glaucoma surgery with mitomycin C: phacoemulsification-trabeculectomy compared to phacoemulsification-deep sclerectomy.
Topics: Aged; Cataract; Combined Modality Therapy; Female; Glaucoma; Humans; Intraocular Pressure; Intraoper | 2005 |
Results of combined phacoemulsification and trabeculectomy with mitomycin C in pseudoexfoliation versus non-pseudoexfoliation glaucoma.
Topics: Aged; Cataract; Exfoliation Syndrome; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intra | 2005 |
Effects of combined cataract surgery and trabeculectomy with mitomycin C on ocular dimensions.
Topics: Aged; Aged, 80 and over; Biometry; Cataract; Cornea; Eye; Female; Glaucoma; Humans; Intraocular Pres | 2005 |
Trabeculectomy and phacotrabeculectomy, with mitomycin-C, show similar two-year target IOP outcomes.
Topics: Adult; Antibiotics, Antineoplastic; Cataract; Follow-Up Studies; Glaucoma; Humans; Intraocular Press | 2006 |
The effect of the timing of scleral flap suture release on the safety and long-term success of phacotrabeculectomy.
Topics: Antibiotics, Antineoplastic; Cataract; Chemotherapy, Adjuvant; Glaucoma, Open-Angle; Humans; Lens Im | 2006 |
Review of consecutive phacotrabeculectomies supplemented with early needle revision and antimetabolites.
Topics: Aged; Aged, 80 and over; Antimetabolites; Cataract; Female; Fluorouracil; Glaucoma; Humans; Intraocu | 2006 |
Phacotrabeculectomy with mitomycin C in patients with uveitis.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Alkylating Agents; Case-Control Studies; Cataract; Co | 2006 |
Phacotrabeculectomy study.
Topics: Alkylating Agents; Antihypertensive Agents; Cataract; Fluorouracil; Glaucoma; Humans; Intraocular Pr | 2007 |
Combined phacoemulsification and deep sclerectomy (PDS) with intraoperative mitomycin C (MMC) augmentation.
Topics: Aged; Aged, 80 and over; Cataract; Combined Modality Therapy; Female; Glaucoma; Humans; Intraocular | 2008 |
Consultation section: cataract surgical problem.
Topics: Anisometropia; Anterior Chamber; Cataract; Choroid Diseases; Combined Modality Therapy; Female; Glau | 2007 |
Suprachoroidal hemorrhage following removal of releasable suture after combined phacoemulsification-trabeculectomy.
Topics: Aged; Alkylating Agents; Cataract; Choroid Hemorrhage; Combined Modality Therapy; Exfoliation Syndro | 2007 |
Comparison of posterior capsule opacification in rabbits receiving either mitomycin-C or distilled water for sealed-capsule irrigation during cataract surgery.
Topics: Animals; Antimetabolites; Cataract; Lens Capsule, Crystalline; Mitomycin; Phacoemulsification; Rabbi | 2007 |
Effect of mitomycin C and fluorouracil-supplemented trabeculectomies on the anterior segment.
Topics: Aged; Anterior Eye Segment; Cataract; Cell Count; Chemotherapy, Adjuvant; Female; Fluorouracil; Glau | 1995 |
Combined phacoemulsification, posterior chamber intraocular lens implantation, and trabeculectomy with mitomycin C.
Topics: Adult; Aged; Aged, 80 and over; Cataract; Cataract Extraction; Female; Follow-Up Studies; Glaucoma; | 1995 |
One-year follow-up results of combined mitomycin C trabeculectomy and extracapsular cataract extraction.
Topics: Adult; Aged; Astigmatism; Cataract; Cataract Extraction; Female; Fluorouracil; Follow-Up Studies; Gl | 1995 |
Prevention of secondary cataract by antimitotic drugs: experimental study.
Topics: Animals; Antineoplastic Agents; Cataract; Cataract Extraction; Cell Count; Fluorouracil; Lens Capsul | 1996 |
Limbus- versus fornix-based conjunctival flaps in combined phacoemulsification and mitomycin C trabeculectomy surgery.
Topics: Aged; Cataract; Conjunctiva; Female; Follow-Up Studies; Glaucoma; Humans; Intraocular Pressure; Lens | 1997 |
Mitomycin against posterior capsular opacification: an experimental study in rabbits.
Topics: Animals; Cataract; Cataract Extraction; Mitomycin; Postoperative Complications; Postoperative Period | 1996 |
Midterm follow-up results of combined phacoemulsification, lens implantation, and mitomycin-C trabeculectomy procedure.
Topics: Aged; Antibiotics, Antineoplastic; Cataract; Female; Follow-Up Studies; Glaucoma; Humans; Intraocula | 1997 |
Mitomycin-C supplemented trabeculectomy, phacoemulsification, and foldable lens implantation.
Topics: Aged; Cataract; Cataract Extraction; Equipment Design; Female; Humans; Intraocular Pressure; Lenses, | 1997 |
Comparative results of combined procedures for glaucoma and cataract: II. Limbus-based versus fornix-based conjunctival flaps.
Topics: Administration, Topical; Aged; Antibiotics, Antineoplastic; Cataract; Conjunctiva; Female; Follow-Up | 1997 |
Echographic diagnosis of scleral fold in hypotony.
Topics: Cataract; Diagnosis, Differential; Eye Foreign Bodies; Female; Humans; Intraocular Pressure; Middle | 1997 |
Combined phacoemulsification and trabeculectomy with mitomycin-C.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Cataract; Chemotherapy, Adjuvant; Female; Foll | 1997 |
An image analysis study of cataract development after trabeculectomy with mitomycin C.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Cataract; Female; Follow-Up Studies; Glaucoma, Open-Angle; | 1998 |
Primary glaucoma triple procedure in patients with primary open-angle glaucoma.
Topics: Cataract; Cataract Extraction; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lens Implantation | 1998 |
Comparison of phacotrabeculectomy with 5-fluorouracil, mitomycin-C, and without antifibrotic agents.
Topics: Aged; Cataract; Chemotherapy, Adjuvant; Fibrosis; Fluorouracil; Glaucoma; Humans; Intraocular Pressu | 1999 |
Effect of phacoemulsification surgery on hypotony following trabeculectomy surgery.
Topics: Aged; Aged, 80 and over; Cataract; Chemotherapy, Adjuvant; Chronic Disease; Female; Glaucoma; Humans | 2000 |
Effect of mitomycin-C on posterior capsule opacification in rabbit eyes.
Topics: Adjuvants, Immunologic; Animals; Antibiotics, Antineoplastic; Cataract; Cell Division; Drug Combinat | 2000 |
Outcomes of combined cataract extraction, lens implantation, and trabeculectomy surgeries.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimetabolites; Cataract; Cataract Extraction; Female; | 2000 |
Long term results and complications of trabeculectomy augmented with low dose mitomycin C in patients at risk for filtration failure.
Topics: Aged; Cataract; Female; Glaucoma; Humans; Intraocular Pressure; Macula Lutea; Male; Middle Aged; Mit | 2001 |
Prevention of posterior capsule opacification by intraoperative single-dose pharmacologic agents.
Topics: Animals; Cataract; Dexamethasone; Diclofenac; Drug Therapy, Combination; Edetic Acid; Epithelial Cel | 2001 |
Prevention of posterior capsule opacification by retinoic acid and mitomycin.
Topics: Animals; Antimetabolites; Cataract; Cell Division; Epithelial Cells; Intraoperative Period; Lens Cap | 2001 |
Comparison of long-term incidence of posterior capsular opacification between phacoemulsification and phacotrabeculectomy.
Topics: Aged; Antimetabolites; Case-Control Studies; Cataract; Female; Glaucoma, Open-Angle; Humans; Inciden | 2002 |
Phacotrabeculectomy: peripheral iridectomy or no peripheral iridectomy?
Topics: Aged; Aged, 80 and over; Cataract; Female; Glaucoma; Humans; Intraocular Pressure; Iris; Lens Implan | 2002 |
Serious complications of topical mitomycin-C after pterygium surgery.
Topics: Adult; Aged; Calcinosis; Cataract; Contraindications; Corneal Diseases; Eye Diseases; Female; Humans | 1992 |